MyAverix Finance
US · Healthcare
Sumitomo Dainippon Pharma Co. Ltd (DNPUF)
Drug Manufacturers - Specialty & Generic
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $5.38B, P/E ratio is 5.36, net margin is 24.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for DNPUF
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) — FAQ
What is Sumitomo Dainippon Pharma Co. Ltd's market cap?
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) has a reported market cap of $5.38B (data as of 2026-03-30).
What is DNPUF's P/E ratio?
The price-to-earnings (P/E) ratio for Sumitomo Dainippon Pharma Co. Ltd (DNPUF) is 5.36 (data as of 2026-03-30).
Does Sumitomo Dainippon Pharma Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Sumitomo Dainippon Pharma Co. Ltd (DNPUF). Check the MyAverix Finance app for the latest dividend data.
What sector is Sumitomo Dainippon Pharma Co. Ltd in?
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is DNPUF listed on?
DNPUF is listed on US.
What is Sumitomo Dainippon Pharma Co. Ltd's net margin?
Sumitomo Dainippon Pharma Co. Ltd (DNPUF) reports a net margin of 24.3% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.